Vergoeding 2017-2021 voor ATC-subgroep R06AX : Overige antihistaminica voor systemisch gebruik
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| R06AX13 Loratadine (Hooikoortstablet loratadine htp ®) | 286.070 | 286.290 | 285.590 | 299.130 | 285.910 |
| R06AX17 Ketotifen (Zaditen ®) | 132.070 | 148.170 | 149.080 | 144.980 | 154.580 |
| R06AX18 Acrivastine (Semprex ®) | 161.610 | 170.100 | 179.080 | 203.760 | 201.790 |
| R06AX22 Ebastine (Kestine ®) | 282.900 | 269.950 | 279.280 | 274.560 | 250.620 |
| R06AX25 Mizolastine (Mizollen ®) | 514.080 | 518.220 | 550.440 | 578.530 | 572.200 |
| R06AX26 Fexofenadine (Telfast ®) | 1.509.600 | 1.622.100 | 1.889.800 | 1.814.800 | 1.948.000 |
| R06AX27 Desloratadine (Aerius ®) | 4.646.400 | 4.742.900 | 4.996.700 | 3.916.500 | 4.435.000 |
| R06AX28 Rupatadine (Rupafin ®) | 356.580 | 365.670 | 512.780 | 635.440 | 714.820 |
| Totaal | 7.889.310 | 8.123.400 | 8.842.750 | 7.867.700 | 8.562.920 |